SCHEMBL7793442

SCHEMBL7793442

CCS(NC(C)=O)(SCC(NC(C)=O)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
CA2 P00918 4/20 0.42
CA1 P00915 4/20 0.42
KMT2A Q03164 2/20 0.42
CA5A P35218 2/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
CA12 O43570 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
CACNA1C Q13936 1/20 0.41
SCN9A Q15858 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
EGFR P00533 1/20 0.40
SRC P12931 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799269 0.88 MTNR1A (0.45) POLBCA2CA1CA5AMMP8
SCHEMBL7793398 0.86 L3MBTL1 (0.46) POLBCA2KMT2ACTSSCTSK
SCHEMBL7798895 0.82 NPC1 (0.50) KMT2ACTSSCTSKMMP8
SCHEMBL7802324 0.82 ITGB3 (0.48) HPGD
SCHEMBL7793458 0.82 MMP1 (0.49) POLBKMT2AMEN1ALDH1A1HPGD
SCHEMBL7798890 0.80 NPC1 (0.48) KMT2ACTSSCTSKMEN1ALDH1A1
SCHEMBL7793435 0.79 CA12 (0.52) POLBCA2CA1KMT2ACA5A
SCHEMBL7803207 0.79 POLB (0.43) POLBCA2CA1KMT2ACA5A
SCHEMBL7793421 0.79 POLB (0.43) POLBCA2CA1KMT2ACA5A
SCHEMBL7798918 0.78 POLB (0.42) POLBCA2CA1KMT2ACA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed